Stock Ticker

  • Loading stock data...

Titan Pharmaceuticals Announces $4.25 Million Stock Purchase Agreement to Commercialize Probuphine (TTNP)

Titan Pharmaceuticals (OTC: TTNP) has taken another step forward in its quest to develop treatment options for opioid dependence using the substance Probuphine. The company has just entered a Stock Purchase and Option Agreement with an affiliate company that is a potential licensee of the commercialization rights of Probuphine. The $4.25 million Stock Purchase and […]

Sign Up To Get Our Latest Stocks Alerts